Psychiatric Problems in Children With Acute Lymphoblastic Leukemia and Their Caregivers
1 other identifier
observational
90
1 country
1
Brief Summary
Cancer in childhood represents a significant health challenge, with approximately 400,000 children and adolescents aged 0-19 years diagnosed annually. The oncological landscape of pediatric populations is characterized by diverse malignancies, with leukemias, brain cancers, lymphomas, and solid tumors such as neuroblastoma and Wilms tumors constituting the predominant diagnostic categories. Among these, acute lymphoblastic leukemia (ALL) emerges as the most prevalent childhood malignancy. Historically, a cancer diagnosis portended an almost invariably fatal outcome. However, contemporary medical interventions have dramatically transformed this narrative. Since 1980, mortality rates across pediatric cancer types have declined by more than 50%, representing a remarkable advancement in clinical oncology. Notably, ALL demonstrates an exceptionally optimistic prognosis, with over 90% of patients achieving complete remission. Despite these encouraging survival statistics, the cancer experience extends beyond physiological parameters. Children diagnosed with leukemia and their familial support systems frequently encounter complex psychological challenges. These manifestations encompass a spectrum of emotional responses, including anxiety, shock, denial, depression, and adaptive difficulties. Critically, these psychological sequelae are not confined to the diagnostic and treatment phases but often persist even after disease remission The multidimensional nature of the cancer experience prompted the emergence of a specialized subdiscipline in 1992. Termed "psycho-oncology" in the United States and "psychosocial oncology" predominantly in European contexts, this field addresses two fundamental psychological dimensions: Emotional and psychosocial responses of patients, families, and caregivers throughout the disease trajectory Psychological, behavioral, and social factors potentially influencing cancer morbidity and mortality. Consequently, contemporary pediatric oncological care adopts a holistic paradigm. The therapeutic objective transcends mere physical restoration, aspiring to ensure the comprehensive social and emotional well-being of both the child and the familial ecosystem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 29, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedDecember 9, 2024
December 1, 2024
1 year
November 29, 2024
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of psychiatric comorbidity in children with ALL and their caregivers at different stages of illness at South Egypt cancer institute
through study completion, an average of 1 year
Study Arms (2)
cases group
children with ALL
healthy control group
Interventions
is a checklist parents complete to detect emotional and behavioral problems in children and adolescent, it consists of 113 questions.
It includes a list of 12 cancer -related stressors (e.g., missing school, frequent hospital or clinic visits, changes in personal appearance), and 57 items reflecting voluntary (coping) and involuntary (automatic) stress responses of children /adolescents in response to cancer-related stressors
It is a method to evaluate psychological problems and identify symptoms, it includes 90 symptoms and evaluate nine symptomatic dimensions
It is a 20 -item measure that assess the 20 DSM-5 symptoms of PTSD.
Eligibility Criteria
The investigators will recruit two groups; first group will be new cases with ALL with their caregivers attending outpatient clinic or admitted inpatient oncological ward and the second group will be healthy control children with their caregivers. Regarding cases group, every patient will be followed for 6 months with the assessment at diagnosis, post induction phase, post consolidation phase and after 3months from the beginning of the maintenance phase.
You may qualify if:
- Newly diagnosed with ALL
- Aged 6 to 18 years old.
You may not qualify if:
- Children with malignancies other than ALL.
- Age \<6 years old and \>18 years old.
- Children with chronic illness e.g., diabetes mellitus, inflammatory bowel disease, congenital heart disease, cerebral palsy, etc.
- Children with history of psychiatric illness or intellectual disability.
- the caregivers:
- The caregivers who are in charge of the case children during treatment.
- The caregivers with history of psychiatric illness.
- B) Control groups:
- the control children:
- Children with matched age and gender to case group.
- Children with history of having malignancy or current malignancy.
- Children with history of medical, chronic illness or psychiatric disorders.
- the control caregivers:
- Caregivers with matched age and gender to the caregivers' case group.
- Caregivers with history of psychiatric illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assiut Universitylead
- South Egypt Cancer Institutecollaborator
Study Sites (1)
Faculty of Medicine,Assiut university,Assiut,Egypt
Asyut, Egypt
Related Publications (2)
Spinetta JJ, Jankovic M, Masera G, Ablin AR, Barr RD, Ben Arush MW, D'Angio GJ, Van Dongen-Melman J, Eden T, Epelman C, Martins AG, Greenberg ML, Kosmidis HV, Oppenheim D, Zeltzer PM. Optimal care for the child with cancer: A summary statement from the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer. 2009 Jul;52(7):904-7. doi: 10.1002/pbc.21863.
PMID: 19142992BACKGROUNDHolland JC. Psycho-oncology: Overview, obstacles and opportunities. Psychooncology. 2018 May;27(5):1364-1376. doi: 10.1002/pon.4692.
PMID: 29749682BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of neurology and psychiatry department
Study Record Dates
First Submitted
November 29, 2024
First Posted
December 9, 2024
Study Start
June 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
December 9, 2024
Record last verified: 2024-12